Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 14, 2021

SELL
$5.03 - $8.8 $1.81 Million - $3.16 Million
-359,100 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$4.04 - $5.31 $60,600 - $79,650
-15,000 Reduced 4.01%
359,100 $1.76 Million
Q3 2020

Nov 12, 2020

BUY
$3.64 - $7.76 $1.36 Million - $2.9 Million
374,100 New
374,100 $1.58 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $246M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Parkwood LLC Portfolio

Follow Parkwood LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.